These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6180672)

  • 21. [Pediatric laryngeal papillomatosis: our experience (three cases)].
    Rodrigo Chiner O; Gisbert Aguilar J; Sánchez Alcón MD; Morera Pérez C
    Acta Otorrinolaringol Esp; 1995; 46(5):365-6. PubMed ID: 8554807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The treatment of laryngeal papillomatosis with interferon inducers].
    Karimova FS; Ivanchenko GF; Grigorian SS
    Vestn Otorinolaringol; 2000; (5):54-7. PubMed ID: 11051860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alpha-interferon treatment of juvenile laryngeal papillomatosis in adults].
    Schuurman AM; van den Broek P
    Ned Tijdschr Geneeskd; 1985 Dec; 129(52):2507-9. PubMed ID: 4088374
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experience in the use of viferon suppositories in young children with juvenile respiratory papillomatosis (preliminary report)].
    Onufrieva EK; Malinovskaia VV; Maslova IV; Nurmukhametov RKh; Kol'tsov VD
    Vestn Otorinolaringol; 1996; (4):32-3. PubMed ID: 8966876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of indinol in antirecurrence therapy of juvenile respiratory papillomatosis].
    Soldatskiĭ IuL; Kiselev VI; Onufrieva EK; Steklov AM; Shchepin NV; Strygina IuV; Gasparian SF; Pogosova IE
    Vestn Otorinolaringol; 2006; (1):46-8. PubMed ID: 16482011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Congenital juvenile respiratory papillomatosis of the larynx].
    Bogomil'skiĭ MR; Soldatskiĭ IuL; Maslova IV; Nurmukhametov RKh
    Vestn Otorinolaringol; 1998; (6):28-9. PubMed ID: 10081396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Laryngeal papillomatosis].
    Viñals RP
    An R Acad Nac Med (Madr); 1985; 102(2):185-211. PubMed ID: 2416235
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diagnosis and treatment of juvenile recurrent laryngeal papillomatosis].
    Wang HG; Lin XQ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Dec; 38(6):421-5. PubMed ID: 15040102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Assessment of the formation of antibodies to interferon in patients with juvenile respiratory papillomatosis on interferon therapy].
    Kol'tsov VD; Chireshkin DG; Onufrieva EK; Nurmukhametov RKh; Malinovskaia VV; Ershov FI
    Vestn Otorinolaringol; 1996; (4):25-7. PubMed ID: 8966873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The results of treatment of juvenile laryngeal papillomatosis in the light of experience of the ENT department in Krakow].
    Olszewski E; Modrzejewski M; Kotarba E; Dobroś W
    Otolaryngol Pol; 1993; 47(3):237-41. PubMed ID: 8414539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of papillomatosis of the larynx with ethyleneimines].
    Kurilin IA; Gorbachevskii VN
    Zh Ushn Nos Gorl Bolezn; 1967; 27(3):20-5. PubMed ID: 5621382
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of alpha-leukocyte interferon on laryngeal papillomatosis in children].
    Vacher S; Peytral C; Narcy P
    Presse Med; 1985 Jun; 14(24):1317-8. PubMed ID: 3161020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Laryngeal papillomatosis in Cameroon (Central Africa). Anatomical aspects].
    Mbakop A; Fouda Onana A; Bengono G; Sunjoh FL; Abondo A
    Ann Otolaryngol Chir Cervicofac; 1991; 108(8):484-6. PubMed ID: 1789625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Side effects of long-term treatment with human leukocyte interferon.
    Ingimarsson S; Cantell K; Strander H
    J Infect Dis; 1979 Oct; 140(4):560-3. PubMed ID: 292735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurologic sequelae following interferon therapy of juvenile laryngeal papilloma.
    Vesikari T; Nuutila A; Cantell K
    Acta Paediatr Scand; 1988 Jul; 77(4):619-22. PubMed ID: 2455956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical and molecular biology studies of laryngeal papillomatosis].
    Mahnke CG; Werner JA; Fröhlich O; Lippert BM; Hoffman H; Rudert HH
    Laryngorhinootologie; 1998 Jan; 77(1):27-33. PubMed ID: 9522309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lysozyme in the treatment of juvenile laryngeal papillomatosis. A new concept in its etiopathogenesis].
    Altamar-Ríos J
    An Otorrinolaringol Ibero Am; 1990; 17(5):495-504. PubMed ID: 2288400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The analysis of the effectiveness of the combined treatment of the patients presenting with laryngeal papillomatosis].
    Svistushkin VM; Starostina SV; Egorov VI; Ragimov AA; Mustafaev DM; Matveev AV; Volkova KB
    Vestn Otorinolaringol; 2017; 82(1):47-51. PubMed ID: 28252590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regression of aggressive laryngeal papillomatosis with 13-cis-retinoic acid (accutane).
    Alberts DS; Coulthard SW; Meyskens FL
    J Biol Response Mod; 1986 Apr; 5(2):124-8. PubMed ID: 3461133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A scheduled protocol for the treatment of juvenile recurrent respiratory papillomatosis with intralesional cidofovir.
    Chhetri DK; Shapiro NL
    Arch Otolaryngol Head Neck Surg; 2003 Oct; 129(10):1081-5. PubMed ID: 14568791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.